| Literature DB >> 31795427 |
Qiwu Zhong1, Bin Wei1, Sijia Wang1,2, Songze Ke1, Jianwei Chen1, Huawei Zhang1, Hong Wang1.
Abstract
Marine-derived antioxidant polysaccharides have aroused extensive attention because of their potential nutritional and therapeutic benefits. However, the comprehensive comparison of identified marine-derived antioxidant polysaccharides is still inaccessible, which would facilitate the discovery of more efficient antioxidants from marine organisms. Thus, this review summarizes the sources, chemical composition, structural characteristics, and antioxidant capacity of marine antioxidant polysaccharides, as well as their protective in vivo effects mediated by antioxidative stress reported in the last few years (2013-2019), and especially highlights the dominant role of marine algae as antioxidant polysaccharide source. In addition, the relationships between the chemical composition and structural characteristics of marine antioxidant polysaccharides with their antioxidant capacity were also discussed. The antioxidant activity was found to be determined by multiple factors, including molecular weight, monosaccharide composition, sulfate position and its degree.Entities:
Keywords: antioxidant activity; chemical composition; marine organisms; polysaccharides; structural characteristics; structure–activity relationship
Mesh:
Substances:
Year: 2019 PMID: 31795427 PMCID: PMC6950075 DOI: 10.3390/md17120674
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Antioxidant polysaccharides derived from marine organisms reported during the years 2013–2019.
| Source | Chemical and Mono-Saccharide Composition (% or Molar Ratio) | Average Mw (kDa) | Sulfate Content (%) | Antioxidant Activity | Place of Origin | References |
|---|---|---|---|---|---|---|
|
| ||||||
|
| Proteins: 3.16 ± 0.50; Total phenolic: 4.83 ± 0.16; Fuc: Rha: Gal: Glu: Man: Xyl = 33.3: 3.7: 7.1: 29.6: 19.2: 7.2 | 11.80 ± 0.79 | DPPH (IC50 = 3.22 µg/mL); Hydroxyl (IC50 = 48.35 µg/mL) | Galle, Sri Lanka | [ | |
|
| 19.8 | 11.4 | Hydroxyl (63.3% at 10.0 mg/mL) | Dalian coast in Liaoning province of China | [ | |
| 7.6 | 1 | Hydroxyl (50.2% at 10.0 mg/mL) | ||||
| 135.6 | 17.6 | Hydroxyl (53.9% at 10.0 mg/mL) | ||||
|
| Uronic acid: 13.94 ± 1.17; Total phenolic: 2.05 ± 0.18 | 5.44 ± 0.85 | DPPH (27% at 2.0 mg/mL) | Puerto Morelos, Mexico | [ | |
|
| Uronic acid: 11.3; Fuc: Ga: Xyl: Rha: Glu = 61.1: 27.2: 7.0: 3.9: 0.8 | 18 to 359 × 103 | 20.1 | DPPH (IC50 = 0.73 mg/mL); Peroxyl (IC50 = 0.48 mg/mL) | Jeju Island, South Korea | [ |
|
| 28.95 | 17.77 | DPPH (IC50 = 4.64 mg/mL) | China coast | [ | |
| 46.17 | 30.38 | DPPH (IC50 = 4.50 mg/mL) | ||||
|
| Protein: 0.8; Gal: Xyl: Fuc = 36.8: 0.1: 29.2 | 35 | 32.6 | DPPH (36.3% at 10 mg/mL) | Buzios | [ |
|
| 1076 ± 30.27 | 20.37 ± 1.15 | DPPH (IC50 = 3.96 mg/mL); Hydroxyl (IC50 = 4.12 mg/mL) | Jiangsu province, China | [ | |
|
| 886 ± 22.01 | 21.75 ± 1.10 | DPPH (IC50 = 4.04 mg/mL); Hydroxyl (IC50 = 4.37 mg/mL) | Jiangsu province, China | [ | |
| 794 ± 19.52 | 22.03 ± 1.22 | DPPH (IC50 = 3.88 mg/mL); Hydroxyl (IC50 = 3.07 mg/mL) | ||||
| 676 ± 24.79 | 20.26 ± 1.06 | DPPH (IC50 = 3.65 mg/mL); Hydroxyl (IC50 = 3.38 mg/mL) | ||||
|
| Uronic acid: 11.87 ± 0.64; Total phenolic: 1.28 ± 0.05 | 5.18 ± 0.41 | DPPH (22% at 2.0 mg/mL) | Puerto Morelos, Mexico | [ | |
|
| 627.18 and 240.02 | 23.84 ± 0.08 | DPPH (35-45% at 1.0 mg/mL); ABTS (75-80% at 0.2 mg/mL) | Pingtung, Taiwan province, China | [ | |
| 628.97 and 237.26 | 23.59 ± 0.41 | DPPH (35-45% at 1.0 mg/mL); ABTS (50-60% at 0.2 mg/mL) | ||||
| 641.20 and 209.35 | 22.08 ± 0.55 | DPPH (45-50% at 1.0 mg/mL); ABTS (50-60% at 0.2 mg/mL) | ||||
|
| Fuc: Gal: Man: Xyl = 65.7: 24.0: 3.5: 6.7 | 3.7 ± 1.54 | DPPH (51.99% at 80 μg/mL) | Tuticorin coast, India | [ | |
|
| Uronic acid: 6.57 ± 0.30; Total phenolic: 1.83 ± 0.04 | 3.78 ± 0.65 | DPPH (14% at 2.0 mg/mL) | Puerto Morelos, Mexico | [ | |
|
| 690.8 and 327.1 | 6.38 ± 0.05 | DPPH (IC50 = 4.30 mg/mL); Ferrous ion-chelating (IC50 = 0.65 mg/mL); Reducing (IC50 = 0.70 mg/mL) | Kenting, southern Taiwan | [ | |
| 568.4 and 287.3 | 7.00 ± 0.06 | DPPH (IC50 = 4.27 mg/mL); Ferrous ion-chelating (IC50 = 0.93 mg/mL); Reducing (IC50 = 0.60 mg/mL) | ||||
| 636.9 and 280.4 | 6.67 ± 0.24 | DPPH (IC50 = 4.57 mg/mL); Ferrous ion-chelating (IC50 = 4.09 mg/mL); Reducing (IC50 = 0.45 mg/mL) | ||||
| 577.8 and 271.4 | 11.42 ± 0.03 | DPPH (IC50 = 5.15 mg/mL); Ferrous Lon-chelating (IC50 = 1.04 mg/mL); Reducing (IC50 = 0.70 at 2.0 mg/mL) | ||||
|
| 1.58 × 103 | 19.41 | DPPH (85.01% at 2.5 mg/mL); Superoxide (65.0% at 2.5 mg/mL); Hydroxyl (98.07% at 2.5 mg/mL) | Zhejiang province, China | [ | |
| 1.92 × 103 | 13.15 | DPPH (73.96% at 2.5 mg/mL); Superoxide (64.5% at 2.5 mg/mL); Hydroxyl (85.56% at 2.5 mg/mL) | ||||
| 11.2 × 103 | 11.4 | DPPH (71.74% at 2.5 mg/mL); Superoxide (35.0% at 2.5 mg/mL); Hydroxyl (47.57% at 2.5 mg/mL) | ||||
|
| Uronic acid: 3.9 ± 1.8; Fuc: Gal: Xyl: Glu: Rha: Man = 46.8: 14.3: 13.2: 11.5: 8.6: 5.6 | 22.35 ± 0.23 | DPPH (61.22% at 1.0 mg/mL); Reducing (67.56% at 1.0 mg/mL); TAC (65.30% at 1.0 mg/mL) | The Gulf of Mannar region, Tamilnadu, India. | [ | |
|
| 190.4 | 15.2 | DPPH (95.23% at 0.4 mg/mL); Hydroxyl (67.56% at 0.8 mg/mL) | Changdao, Shangdong province, China | [ | |
| 315.3 | 11.4 | DPPH (90.80% at 0.4 mg/mL); Hydroxyl (68.7% at 0.8 mg/mL) | ||||
|
| Protein: 4.2 ± 0.56; Fuc: Gal: Man: Rha: Xyl = 60.9: 25.2: 4.2: 6.3: 3.4 | 21.35 ± 0.81 | DPPH (52.30% at 0.1 mg/mL); Reducing (60.15% at 0.1 mg/mL) | Tamil Nadu, India | [ | |
|
| 22.7 | DPPH (IC50 = 534.45 µg/mL); ABTS (IC50 = 323.8 µg/mL) | Tuticorin coast, India | [ | ||
|
| Uronic acid: 11.42 ± 0.03; Protein: 1.81 ± 0.035; Total phenol: 6.16 ± 0.36 | 27 ± 1.49 | ABTS (IC50 = 88.71 µg/mL); DPPH (IC50 = 440.07 µg/mL); Superoxide (IC50 = 352 µg/mL) | Tamil Nadu, India | [ | |
|
| 81 | 6.96 | DPPH (53.45% at 1.0 mg/mL) | Great Barrier Island, New Zealand | [ | |
| 22 | 22.78 | DPPH (58.65% at 1.0 mg/mL) | ||||
| 27 | 25.19 | DPPH (68.65% at 1.0 mg/mL) | ||||
| 80.3 | 23.5 | Hydroxyl (59.1% at 10.0 mg/mL) | ||||
|
| ||||||
|
| Uronic acid: 1.35; Protein: 2.30; Rha: Xyl: Glu: Fru: Gal: Fuc = 0.35: 0.2: 0.66: 0: 0: 0.8: 0 (molar ratio) | 24.1 | Superoxide (64.37% at 90 µg/mL); DPPH (23.49% at 0.1 mg/mL) | NanjiArchipelago coast of China | [ | |
|
| 1310 | 5.96 ± 0.91 | DPPH (41.59% at 2.5 mg/mL); Superoxide (64.78% at 2.5 mg/mL); ABTS (59.01% at 2.5 mg/mL) | Dayang Foodstuff Co.; Ltd | [ | |
| 691 | 8.46 ± 0.75 | DPPH (30.67% at 2.5 mg/mL); Superoxide (50.47% at 2.5 mg/mL); ABTS (47.55% at 2.5 mg/mL) | ||||
| 923 | 12.03 ± 0.80 | DPPH (22.84% at 2.5 mg/mL); Superoxide (64.28% at 2.5 mg/mL); ABTS (50.49% at 2.5 mg/mL) | ||||
|
| 909.5 to 71.70 | 0.7 | Alkyl (IC50 = 191.4 µg/mL); H2O2 (IC50 = 91.0 µg/mL) | Wando Island coast of South Korea | [ | |
| 3.93 to 0.60 | 0.9 | Alkyl (IC50 = 114.4 µg/mL); H2O2 (IC50 = 13.0 µg/mL) | ||||
| 0.9 | Alkyl (IC50 = 197.5 µg/mL); H2O2 (IC50 = 95.0 µg/mL) | |||||
|
| Man: Glc: Sor: Ara = 14.4: 5.3: 2.8: 1.2 (molar ratio) | 466 | Hydroxyl (83.33% at 4 mg/mL); ABTS (IC50 = 3.99 mg/mL) | Antarctic algae Co. (Xiamen, China) | [ | |
|
| Total sugar: 66.0 | 210.9 | 6.5 | DPPH (88.93% at 4.0 mg/mL); ABTS (IC50 = 2.01 mg/mL) | Atlantic coast, northeast of Brazil | [ |
|
| ||||||
|
| 21.3 | DPPH (EC50 = 0.84 mg/mL); Superoxide (EC50 = 10.4 µg/mL) | Coast of Ningbo, China | [ | ||
| 17.4 | DPPH (EC50 = 0.96 mg/mL); Superoxide (EC50 = 15.6 µg/mL) | |||||
|
| 1.9 | 22.03 | Superoxide (39.88% at 8 mg/mL); Hydroxyl (45-50% at 1 mg/mL) | Coast of Nanji Archipelago, China | [ | |
| 54.7 | 16.28 | Superoxide (73.74% at 8 mg/mL); Hydroxyl (40-45% at 6 mg/mL);DPPH (20-25% at 1 mg/mL) | ||||
| 262.7 | 13.31 | Superoxide (43.08% at 8 mg/mL); Hydroxyl (40-45% at 1 mg/mL) | ||||
|
| Uronic acid: 35.06; Rha: Xyl: Glu: Fru: Gal: Fuc = 35.21: 17.81: 8.64: 0: 0: 0: 0 (molar ratio) | 19.41 | Superoxide (81.45% at 90 µg/mL); DPPH (37.63% at 0.1 mg/mL) | Nanji Archipelago coast of China | [ | |
|
| 300 | 34–40 | DPPH (56.18% at 3.0 mg/mL); ABTS (68.06% at 3.0 mg/mL) | Pattani Bay, Thailand | [ | |
| 110 | 36–38 | DPPH (>50% at 3.0 mg/mL); ABTS (71.87% at 3.0 mg/mL) | ||||
| 88 | 36–40 | DPPH (55.97% at 3.0 mg/mL); ABTS (61.01% at 3.0 mg/mL) | ||||
|
| 110 | 8.85 | DPPH (the highest 82.23%) | Pattani Bay, Thailand | [ | |
|
| ||||||
| 7.75 | DPPH (42.45 % at 0.1 mg/mL); Hydroxyl (83.54 % at 10 mg/mL) | Copenhagen, Denmark | [ | |||
| Protein: 12; Uronic acid: 24; Fuc: Gal: Ara: Glc: Man: Xyl: Rib: Rha = 32: 16.3: 12.5: 12.1: 11.5: 10.3: 2.7: 2.3 | 11 | Hydroxyl (IC50 = 0.87 mg/mL); Ferrous ion-chelating (IC50 = 0.33 mg/mL) | A hot spring located in the N-E of Tunisia | [ | ||
|
| 15.93 | 54.9 | Superoxide (53.5% at 3.2 mg/mL) | Ocean University of China | [ | |
| 17 | 0.40 ± 0.004 | DPPH (IC50 = 238 µg/mL) | University of Sonora | [ | ||
| 107 | 0.33 ± 0.004 | DPPH (IC50 = 326 µg/mL) | ||||
| 108 | 0.32 ± 0.002 | DPPH (IC50 = 3066 µg/mL) | ||||
|
| 3645 | 16.6 ± 0.37 | DPPH (IC50 = 0.77 mg/mL); Hydroxyl (IC50 = 0.70 mg/mL) | Ocean University of China | [ | |
| 387 | 15.0 ± 1.08 | DPPH (IC50 = 0.56 mg/mL); Hydroxyl (IC50 = 0.52 mg/mL) | ||||
| 55 | 17.8 ± 0.88 | DPPH (IC50 = 0.45 mg/mL); Hydroxyl (IC50 = 0.42 mg/mL) | ||||
| 2595 | 16.1 ± 0.75 | DPPH (IC50 = 0.91 mg/mL); Hydroxyl (IC50 = 0.91 mg/mL) | Ocean University of China | [ | ||
| 453 | 14.0 ± 1.08 | DPPH (IC50 = 0.62 mg/mL); Hydroxyl (IC50 = 0.56 mg/mL) | ||||
| 169 | 17.3 ± 0.56 | DPPH (IC50 = 0.51 mg/mL); Hydroxyl (IC50 = 0.48 mg/mL) | ||||
| 8.69 | 25.4 ± 0.69 | DPPH (IC50 = 0.41 mg/mL); Hydroxyl (IC50 = 0.41 mg/mL) | ||||
|
| ||||||
| 27.4 | 0 | DPPH (EC50 = 3.4 mg/mL); Hydroxyl (EC50 = 4.2 mg/mL) | South Sea, China | [ | ||
|
| 18.6 | 0 | Hydroxyl (EC50 = 2.8 mg/mL) | Yellow Sea, China | [ | |
| 20.5 | Superoxide (EC50 = 2.20 mg/mL); DPPH (EC50 = 0.97 mg/mL) | [ | ||||
|
| Protein: 0.79; Gal: Glu: Man = 1.33: 1.33: 1 (molar ratio) | 61.2 | 0 | Hydroxyl (EC50 = 1.1 mg/mL); Superoxide (EC50 = 2.0 mg/mL); DPPH (EC50 = 2.1 mg/mL) | South Sea, China | [ |
| Man: Glu: Gal = 1.26:1.11:1.01 (molar ratio); Uronic acid: 10 | 8.96 × 105 | DPPH (IC50 = 76.38 mg/mL); Superoxide (IC50 = 67.85 mg/mL) | Tuticorin coast, India | [ | ||
|
| ||||||
|
| Hydroxyl (45.65% at 100 μg/mL); Superoxide (67.31% at 250 μg/mL) | Yellow Sea of China | [ | |||
| 1.95 ± 0.04 | DPPH (IC50 = 0.61 mg/mL); Superoxide (IC50 = 0.65 mg/mL) | Between Someshwara and Malpe, India | [ | |||
| 37.6 | 22.8 | DPPH (IC50 = 0.21 µg/mL); H2O2 (IC50 = 30.04 µg/mL); Superoxide (IC50 = 35.28 µg/mL) | Marsa-Alam | [ | ||
|
| Fru: Gal: Xyl: Glu: Rha: Man = 43.8: 20.0: 17.8: 7.2: 7.1: 4.1 | DPPH (79 % at 1.0 mg/mL); Superoxide (75.12 % at 1.0 mg/mL) | Campbell bay, India | [ | ||
| 0 | DPPH (IC50 = 0.44 mg/mL); Superoxide (IC50 = 0.33 mg/mL) | Between Someshwara and Malpe, India | [ | |||
|
| DPPH (84 % at 10 mg/mL); Superoxide (89.15 % at 0.5 mg/mL); Hydroxyl (61 % at 3.2 mg/mL) | Tuticorin, Southeast coast of India | [ | |||
|
| Glu: Glucosamine: GlcA: Gal: Galactosamine = 1: 0.65: 0.24: 0.22: 0.02; Uronic acid: 12.05 | 801.7 and 206.0 | 2.8 | DPPH (IC50 = 6.03 mg/mL) | Braunschweig, Germany | [ |
| Glu: Ara: GalA: Man = 14.4: 1.2: 1: 0.6 (molar ratio); Protein: 10.52 ± 0.9; Uronic acid: 2.26 ± 0.80 | 269 | 4.36 ± 0.68 | DPPH (IC50 = 0.64 mg/mL); Superoxide (IC50 = 0.19 mg/mL) | Offshore of Cochin, India | [ | |
| 2.20 ± 0.02 | DPPH (IC50 = 0.49 mg/mL); Superoxide (Not scavenging activity) | Between Someshwara and Malpe, India | [ | |||
| 220 | DPPH (55.40% at 10 mg/mL); Hydroxyl (52.1% at 10 mg/mL) | Ny-Ålesund, Svaldbard | [ | |||
|
| ||||||
|
| 93.3 | 3.04 | DPPH (65.9% at 4.0 mg/mL); Nitric oxide (39.3% at 4.0 mg/mL) | Fujian province, China | [ | |
|
| 98.1 | 3.65 | DPPH (48.1% at 4.0 mg/mL); Nitric oxide (25.9% at 4.0 mg/mL) | Nansha Islands of Nanhai Sea, China | [ | |
|
| 1.8671 | 20.7 | Hydroxyl (EC50 = 3.74 mg/mL); Superoxide (EC50 = 0.0378 mg/mL) | [ | ||
|
| 99.7 | 3.21 | DPPH (65-70 % at 4 mg/mL); Superoxide (45-50 % at 4 mg/mL); Hydroxyl (60-65 % at 4 mg/mL) | Weifang city, China | [ | |
| 9.83 | 3.11 | DPPH (50-55 % at 4 mg/mL); Superoxide (35-45 % at 4mg/mL); Hydroxyl (55-60 % at 4 mg/mL) | ||||
|
| 111 | 3.18 | DPPH (68.3% at 4.0 mg/mL); Nitric oxide (34.7% at 4.0 mg/mL) | Xisha Islands, China | [ | |
|
| 1284 | 28.2 ± 3.5 | Superoxide (IC50 = 17.46 µg/mL) | Hainan, China | [ |
AAPH: 2,2’-Azobis(2-amidinopropane) dihydrochloride; ABTS: 2,2’-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid); Ara: Arabinose; Fuc: Fucose; Gal: Galactose; GalA: Galacturonic acid; Glu: Glucose; GalNAc: N-acetylgalactosamine; GlcA: Glucuronic acid; Man: Mannose; Rha: Rhamnose; Xyl: Xylose.
Figure 1Overview of marine-derived polysaccharides in alleviating oxidative stress-mediated diseases.
Protective effects and mechanisms of antioxidant polysaccharides derived from marine organisms.
| Source | Polysaccharides | Test Model | Protective Effect | Potential Mechanism | References |
|---|---|---|---|---|---|
|
| |||||
| Fucoidan | Apolipoprotein E-deficient mice | Anti-atherosclerosis | LPL activity↑, 4-HNE↓, MDA content↓, lipid peroxidation level↓ | [ | |
|
| Fucoidan | CCl4-induced liver injury in mice | Hepatoprotective | MDA content↓, SOD activity↑ | [ |
|
| Fucoidan | HepG2 cells | Antioxidant in vivo | ROS level↓, GSH level↑, CAT activity↑ | [ |
|
| Fucoidan | AAPH-induced oxidative stress in zebrafish model | Antioxidant in vivo | ROS level↓, Lipid peroxidation levels↓, cell death↓ | [ |
| Fucoidan | Ultraviolet B-Irradiated mice | Anti-Photoaging | MDA content↓, ROS level↓, GSH level ↑ | [ | |
|
| Fucoidan | Mesenchymal stem cells and Murine hindlimb ischemia model | Anti-ischemic disease | ROS level↓, MnSOD level↑, GSH level↑, DNA damage↓, p38, JNK and caspase-3↓ | [ |
|
| Fucoidan | Low density lipoprotein receptor-deficient (LDLR-/-) mice | Antiatherosclerosis | NOX4↓, ROS level↓ | [ |
| Fucoidan | Diabetic goto-kakizaki rats | Anti-diabetic | eNOS expression and NO production↓, | [ | |
| Fucoidan | The gentamicin induced nephrotoxicity in rats | kidney protection | AOPP and MDA levels↓, GSH level↑ | [ | |
| Fucoidan | STZ-induced type 1 diabetic rats | Anti-diabetic | ROS level↓, SOD activity↑, GSH level↑ | [ | |
| Fucoidan | NAFLD in diabetes/obesity mice PA-treated HepG2 cells | Hepatoprotective | Hepatic CAT and SOD activity↑, MDA content↓ TNF-α and IL-6 level↓ | [ | |
|
| Galactofucan | Hepatotoxicity induced by CCl4 rats | Hepatoprotective | MPO activity↓, lipid peroxidation level↓ | [ |
| Marine brown algae | Fucoidan | HaCaT cells | Antioxidant in vivo | Nrf2 levels↑, HO-1, SOD-1 activity↑ | [ |
| Fucoidan | Ethanol intoxicated Wistar rats | Hepatoprotective | GSH level↑, ROS level↓, TBARS level↓, SOD, CAT and GPx activity↑, Caspase3 expression↓ | [ | |
| Fucoidan | Cerebral ischemia reperfusion injury Sprague-Dawley rats | Neuroprotection | SOD and MDA levels↓, IL-1β, IL-6, MPO and TNF-α levels↓, p-p38 and p-JNK levels↓ | [ | |
| Fucoidan | HFD-induced NAFLD rats | Hepatoprotective | Hepatic MDA and NO levels↓, GSH↑, IL-1β and MMP-2 levels↓ | [ | |
|
| Fucoidan | HepG2 cells | Antioxidant in vivo | ROS level↓, GSH level↑, CAT activity↑ | [ |
|
| Fucoidan | H2O2-treated PC-12 cells | Neuroprotection | The sub-G1 DNA populations↓, the S phase populations↓ | [ |
|
| Fucoidan | HepG2 cells | Antioxidant in vivo | ROS level↓, GSH level↑, CAT activity↑ | [ |
|
| Fucoidan | D-Gal-treated ICR mice | Anti-aging | SOD and CAT activities↑, MDA content↓, protein levels of Nrf2, Bcl-2, p21 and JNK1/2↑, Cu/Zn-SOD, Mn-SOD and GPX1 activity↑ | [ |
|
| Fucoidan | MPTP-treated C57BL/6 mice | Neuroprotection | DOPAC, and HVA content↑, TBARS level↓, SOD and CAT activity↓, GSH level↑, GPX levels↑, TH and DAT protein levels↑ | [ |
|
| Fucoidan | D-Gal-Induced neurotoxicity in PC12 cells and cognitive dysfunction in Mice | Neuroprotection | SOD activity↑, GSH level↑, ACh and ChAT activity↓, AChE activity↑ | [ |
| Fucoidan | Full-thickness dermal excision rat model | Promoting Wound Healing | MDA content↓, CAT and SOD activity↑, GSH level↑, lipid peroxidation level↓ | [ | |
|
| |||||
|
| Sulfated polysaccharides | H2O2-induced oxidative injury in PC12 cells | Anti-aging | ROS level↓, lipid peroxidation↓ | [ |
|
| Sulfated polysaccharides | Trinitrobenzenesulfonic | Anti-colitis | GSH level↑, MDA content↓, NO3/NO2 content↓, MPO activity↓, IL-1β and TNF-α levels↓ | [ |
| sulphated agaran | 6-OHDA-treated Wistar rats | Neuroprotection | DA and DOPAC content↑, GSH ↑, iNOS and IL1β mRNA levels↓, NO2/NO3 levels in brain↑ | [ | |
|
| Sulfated polysaccharides | Ethanol-induced gastric damage in mice | Gastroprotective | GSH levels↑, MDA content↓, NO levels↑ | [ |
|
| Sulfated polysaccharide ASPE | MDA-MB-231 human breast cancer cells | Anti-breast cancer | ROS level↓, Bax/Bcl-2 protein level ratio↓, cleaved caspase-3 protein level↓ | [ |
| Sulfated carrageenan | MDA-MB-231 human breast cancer cells | Anti-breast cancer | Caspase-8 levels↑, caspase-3, caspase-9, p53 protein level ratio↓ | [ | |
| Carrageenans | MCF-7 human breast cancer cells | Anti-breast cancer | Bax/Bcl-2 protein level ratio↓, p53 and caspase-3 protein level↓ | [ | |
|
| Porphyran | H2O2-induced premature senescence in WI-38 cells | Anti-aging | SA-β-gal activity↓, p53 and p21 level↓ | [ |
|
| Iota-carrageenan | Ethanol-induced gastric injury in mice | Gastroprotective | ROS level↓, GSH level↑, MDA content↓ | [ |
|
| Ulvan | MPTP-treated C57BL/6J mice | Neuroprotection | Contents of DA, DOPAC and HVA↑, ratio of DOPAC and HVA to DA↓, TNF-α, IL-1β and IL-6 levels↓ | [ |
|
| Ulvan | Hyperlipidemia rats | Hepatoprotective | MDA content↓ | [ |
|
| Ulvan | J774A.1 cell | Immunostimulation | TNF-α levels↑, NO production↑, IL-1β expression↑ | [ |
|
| Ulvan | D-galactosamine induced liver damage in rats | Hepatoprotective | Lipid peroxide level↓, DNA damage↓, SOD and CAT activities↑ | [ |
| Ulvan | DiethylnitrosamineInitiated and phenobarbital-promoted hepatocarcino genesis in rats | Hepatoprotective | ROS level↓, MDA content↓, hepatic GSH, SOD, CAT, GR, MPO, and GST activity↑ | [ | |
|
| Ulvan | Cholesterol-rich diet rats | Hepatoprotective | MDA content↓, CAT, SOD and GSH-Px activity↑ | [ |
| Ulvan | Hyperlipidemic Kunming mice | Hepatoprotective | MDA content↓, CAT and SOD activity↑, | [ | |
|
| |||||
|
| Polysaccharides | MPTP-treated C57BL/6J mice | Neuroprotective | SOD and GPx activity in serum and midbrain↑, | [ |
|
| |||||
|
| Polysaccharides | Hyperlipidemia mice | Antihyperlipidemic | CAT and SOD activity↑, MDA content↓ | [ |
|
| Animal polysaccharides | Beagle dogs exposed to γ-radiation | Anti-radiation hematopoiesis | SOD activity↑ | [ |
| Animal polysaccharides | A half-lethal dose 137Cs –rays irradiation mice | Anti-radiation hematopoiesis | SOD and GSH-PX activity↑, MDA content↓ | [ | |
|
| Animal polysaccharides | 6-OHDA-exposed SH-SY5Y cells | Neuroprotective | MDA content↓, SOD activity↑, ROS level↓, NO release↓, Bax/Bcl-2 protein level ratio↓, levels of p-p53, p-p65, p-p38, JNK1/2, iNOS↓ | [ |
AAPH: 2,20-Azobis(2-amidinopropane) dihydrochloride; ACh: Acetylcholine; AChE: Acetylcholine esterase; CAT: Catalase; CCl4: Carbon tetrachloride; ChAT: Choline acetyl transferase; Cu/Zn-SOD: Copper-zinc superoxide dismutase; DA: Dopamine; DAT: Dopamine transporter; D-Gal: D-galactose; DOPAC: 3,4-Dihydroxyphenylacetic acid; GR: Glutathione reductase; GSH: Glutathione; GSHPx: Glutathione peroxidase; 4-HNE: 4-hydroxynonenal; H2O2: Hydrogen peroxide; HVA: Homovanillic acid; IL-1β: Interleukins-1 beta; iNOS: Inducible nitric oxide synthase; JNK: Jun N-terminal kinase; MAO: Monoamine oxidase; MDA: Malondialdehyde; MMP-2: Mitochondrial membrane potential-2; MnSOD: Manganese superoxide dismutase; MPTP: 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; MPO: Myeloperoxidase; NAFLD: Non-alcoholic fatty liver disease; NF-κB: Nuclear factor-κB; NO: Nitric oxide; NOX2: Cytochrome b-245β chain; Nrf2: Nuclear factor erythroid 2-related factor 2; 6-OHDA: 6-hydroxydopamine; PC12 cells: Rat pheochromocytoma cell line; ROS: Reactive oxygen Resource; SA-β-gal: Senescence-associated β-galactosidase; SH-SY5Y: Human neuroblastoma cell line; SOD: Superoxide dismutase; SOD-1: Superoxide dismutase-1; TBARS: Thiobarbituric acid reactive substances; TH: Tyrosine hydroxylase; TNF-α: Tumor necrosis factor α.
Figure 2Fucoidan prevents oxidative stress by regulating the antioxidant system.
Figure 3Fucoidan prevents oxidative stress through oxidative stress-related signaling pathway.
Figure 4Structure units of fucoidan from sea cucumber (A) Thelenota ananas and (B) Isostichopus badionotus.